Vulnerability Description
The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to impersonate a legitimate user as long as the device keeps the session active, since the attack takes advantage of the cookie header to generate "legitimate" requests.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Dexma | Dexgate | 20130114 |
Related Weaknesses (CWE)
References
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party AdvisoryUS Government Resource
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party AdvisoryUS Government Resource
FAQ
What is CVE-2023-41089?
CVE-2023-41089 is a vulnerability with a CVSS score of 8.0 (HIGH). The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to impersonate a legitimate user as long as the device keeps the session active, si...
How severe is CVE-2023-41089?
CVE-2023-41089 has been rated HIGH with a CVSS base score of 8.0/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-41089?
Check the references section above for vendor advisories and patch information. Affected products include: Dexma Dexgate.